Buy 5F-MDA19,MDA-19,5CMMDA,5FAEB2201,7abb,7add,7a-19,Ad-18,2f-dck,6cladba,6cl,5cladba,5cl
igh quality research chemicals in large and small quantities… our products are as below: Our products are of high purity (above 99%).
5F-MDA19
MDA-19 (also known as BZO-HEXOXIZID) is a drug that acts as a potent and selective agonist for the cannabinoid receptor CB2, with reasonable selectivity over the psychoactive CB1 receptor, though with some variation between species.
In animal studies it was effective for the treatment of neuropathic pain, but did not effect rat locomotor activity in that specific study.
MDA-19 is a drug that acts as a potent and selective agonist for the cannabinoid receptor CB2, with reasonable
selectivity over the psychoactive CB1 receptor, though with some variation between species. In animal studies it was
effective for the treatment of neuropathic pain, but failed to produce cannabis-like behavioural effects.
The pharmacology of MDA-19 in rat cannabinoid receptors have been demonstrated to function differently than human cannabinoid receptors with MDA-19 binding to human CB1 receptors 6.9x higher than rat CB1 receptors.
5F-MDA19
MDA-19
5CMMDA
5FAEB2201
7abb
7add
7a-19
Ad-18
2f-dck
6cladba
6cl
5cladba
5cl
2f-dck
6cladba
We offer discreet and reliable packaging and delivery. – fast and reliable shipping within 48 hours, using courier,
DHL, EMS, TNT, FEDEX, UPS, these are in stock and we only sell items above 99%, if you are interested Quote the best for you.
MDA-19 (also known as BZO-HEXOXIZID) is a drug that acts as a potent and selective agonist for the cannabinoid
receptor CB2, with reasonable selectivity over the psychoactive CB1 receptor, though with some variation between species.
In animal studies it was effective for the treatment of neuropathic pain, but did not effect rat locomotor activity in that specific study.
The pharmacology of MDA-19 in rat cannabinoid receptors have been demonstrated to function differently than human cannabinoid receptors with MDA-19 binding to human CB1 receptors 6.9x higher than rat CB1 receptors.
